See also this year's filing and all EDGAR filings for this company.
PDF Report 0001346302_2020_Xeris_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001346302, Xeris Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 87,483,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,853,000 |
| 3 | remainder_Assets | 13,651,000 |
| 4 | LiabilitiesCurrent | 27,338,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 67,213,000 |
| 7 | CostOfGoodsAndServicesSold | 1,603,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 63,061,000 |
| 9 | ResearchAndDevelopmentExpense | 60,438,000 |
| 10 | remainder_Expenses | -458,000 |
| 11 | remainder_Revenues | 1,627,000 |
| 12 | remainder_NetIncome | -2,563,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 108,987,000 |
| 1 | Liabilities | 94,551,000 |
| 2 | Expenses | 124,644,000 |
| 3 | Revenues | 1,627,000 |
| 4 | StockholdersEquity | 14,436,000 |
| 5 | NetIncome | -125,580,000 |
| 6 | ComprehensiveNetIncome | -125,580,000 |
| 7 | BaseVar | 166,186,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.925 |
| 9 | EconomicCapitalRatio | 1.32 |
Edgar->Model Mapping
Feature Distribution
